NCT02643693View on ClinicalTrials.gov

User Acceptability of a Nicotine Lactate Delivery System (P3L)

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

December 31, 2016

Conditions
Smoking
Interventions
OTHER

P3L

"Ad libitum use for a maximum of three hours.~P3L delivers, on average, 80 µg of nicotine per puff under Health Canada Intense smoking regime."

OTHER

VUSE

"Ad libitum use for a maximum of three hours.~VUSE delivers, on average, 80 µg of nicotine per puff based on the CORESTA e-cigarette recommended smoking regime."

OTHER

CC

Ad libitum use of the subject's own brand of non-menthol CC for a maximum of three hours.

Trial Locations (1)

27617

Rose Research Center, LLC, Raleigh

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT02643693 - User Acceptability of a Nicotine Lactate Delivery System (P3L) | Biotech Hunter | Biotech Hunter